Prescribe

Malappuram, India Founded: 2019 • Age: 7 yrs
Functions as an AI-based platform for health management, supporting doctors and patients with advanced tools.

About Prescribe

Prescribe was a Technology company based in Malappuram (India) founded in 2019 by Amit Kumar Verma, Nived Narayanan, and Sreeshyam C A. Functions as an AI-based platform for health management, supporting doctors and patients with advanced tools. It operates on a B2B model. Prescribe has raised $260.94 thousand across 2 funding rounds from investors including Angel List, Wellfound and First Cheque. Prescribe was last valued at $897.94 thousand in September 2020. Its Indian entity Wellnexus Technologies Private Limited reported revenue of β‚Ή14.5 Lakh. The company is recorded as dissolved. Its focus areas include Healthcare, Digital Health, Health Management Platforms and AI Solutions. Its competitors include Purple Health, Lytus and Jiyyo; 2 of its 3 listed competitors have raised funding.

Company details

Prescribe, backed by 260940.0 from Y Combinator, Rohit Kumar Bansal, Titan Capital, Mudit Vijayvergiya, Nipun Goyal, Pawan Gupta, Kunal Bahl, Wellfound, First Cheque, Angel List, AngelList, Rohit Bansal, focuses on providing healthcare solutions, providing digital health services, health management platforms, and ai solutions. Functions as an AI-based platform for health management, supporting doctors and patients with advanced tools. Driving innovation, growth, and excellence in its industry sectors.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹14.5 Lakh

    FY 2022 · +146% YoY

  • Net Loss
    -₹7.3 Lakh

    FY 2022 · -50% margin

  • EBITDA
    -₹6.6 Lakh

    FY 2022 · -45% margin

  • Total Equity Funding
    $260.94K (USD)

    in 2 rounds

  • Latest Funding Round
    $125K (USD), Seed

    Mar 2021

  • Investors
    Angel List

    & 11 more

Funding Insights of Prescribe

Prescribe has successfully raised a total of $260.94K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $260,940
  • Total Rounds 2
  • Last Round Seed β€” $125,000
  • First Round $135,940

    (Sep 2020)

  • Investors Count 12

All 2 funding rounds of Prescribe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021$125,000Seed––
Sep 2020$135,940Seed$897,941Titan Capital, Wellfound
Valuation history

Last known valuation $897,941 (Sep 2020). 12 investors in total: 6 institutional and 6 angel.

Investors in Prescribe

Prescribe has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Angel List, Wellfound and First Cheque.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
Investments are made in early-stage companies by Titan Capital.
titancapital.vcGurugram, India
Early-stage investment and support services for startups in technology and e-commerce sectors.
2018firstcheque.vcMumbai, India
Startup jobs are connected to individuals via a dedicated platform.
2013wellfound.comNew York, United States
Alternative investment platform for startups and investors is operated.
2010angellist.comSan Francisco, United States
Startup jobs are connected to seekers via an online platform.
angel.coSan Francisco, United States

Rohit Kumar Bansal

unknown_9356c1d7297e4692b

Mudit Vijayvergiya

Co-founder of Curofy, angel investor in Indian startups
unknown_0162fbdff695427f9

Nipun Goyal

Co-founder of CRED, angel investor in Indian startups
unknown_0ff2e98d81184341b

Pawan Gupta

Angel investor, ex-Director at American Express, focused on fintech and consumer tech.
unknown_9218d32b870a47a3b
Premium access

Investor details for Prescribe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Wellnexus Technologies Private Limited (Prescribe)

Wellnexus Technologies Private Limited is the primary company behind Prescribe. The board of Wellnexus Technologies Private Limited currently have 3 directors; the longest-serving is Chandroth Ambiliyadan Sreeshyam, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Chandroth Ambiliyadan Sreeshyam
DIN 08618664
Director21 Nov 20196 yrs 11 moWellnexus Technologies Private Limited
Nived Narayanan
DIN 08618652
Director21 Nov 20196 yrs 11 moWellnexus Technologies Private Limited
Amit Kumar
DIN 08618663
Director21 Nov 20196 yrs 11 moWellnexus Technologies Private Limited

People of Prescribe

5 people are tracked at Prescribe (3 in leadership, 2 in team).

NameRoleGroup
Amit Kumar Verma
Co-FounderLeadership
Co-FounderLeadership
Sreeshyam C A
Co-FounderLeadership
Shubhra Sisodia
Digital Marketing & Business Development AssociateTeam
Gabrielle Cova
Brand & Communication StrategistTeam
Premium access

Complete people profiles for Prescribe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Prescribe

Figures of Wellnexus Technologies Private Limited, the primary company behind Prescribe, for FY 2022. Revenue was ₹14.5 Lakh (+146% year on year). Net loss was -₹7.3 Lakh (-50% margin). EBITDA was -₹6.6 Lakh (-45% margin).

  • ₹14.5 LakhRevenue · FY 2022 · +146% YoY
  • -₹7.3 LakhNet loss · -50% margin
  • -₹6.6 LakhEBITDA · -45% margin
  • ₹1.2 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Wellnexus Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for Prescribe

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Prescribe

3 dated milestones of Prescribe across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Prescribe is founded.
  2. Funding First funding round of $136K.
  3. Funding Latest funding round, Seed, of $125K.

Competitors of Prescribe

Prescribe has 3 listed competitors in our database, 2 of them funded. They include Purple Health, Lytus and Jiyyo.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
purplehealth.com2014Thiruvananthapuram, India$294,770
Online platform for video consulting with doctors and appointment booking
lytuscorp.com2020Mumbai, India3
Provider of telemedicine services
jiyyo.com2016Chandigarh, India$829,3721
Platform to search prices of medicines and medical procedures
Premium access

Detailed competitors of Prescribe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in AI in Healthcare

3 companies that operate in the same segment as Prescribe (AI in Healthcare) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
AI startup acceleration and networking services are offered globally.
2017Bengaluru, Karnataka, India
AI-based mental health support services for individuals, organizations, and healthcare providers.
2015Bengaluru, Karnataka, IndiaUSD 1.55 M102
AI-powered platform for digitizing prescriptions and enhancing healthcare workflows.
2017Delhi, Delhi, IndiaUSD 9.05 MUSD 3.5 K6
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prescribe

Premium access

Complete news archive for Prescribe

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prescribe

Prescribe was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Prescribe is headquartered in Malappuram, India. It is registered at Malappuram, Kerala, India.

Prescribe is a funded company, having raised a total of $260.94K across 2 funding rounds to date. The company's 1st funding round was a Seed of $135.94K, raised on Sep 2020.

The primary company behind Prescribe, Wellnexus Technologies Private Limited, reported revenue of β‚Ή14.5 Lakh for FY 2022, up 146% year on year.

Prescribe, backed by 260940.0 from Y Combinator, Rohit Kumar Bansal, Titan Capital, Mudit Vijayvergiya, Nipun Goyal, Pawan Gupta, Kunal Bahl, Wellfound, First Cheque, Angel List, AngelList, Rohit Bansal, focuses on providing healthcare solutions, providing digital health services, health management platforms, and ai solutions. Functions as an AI-based platform for health management, supporting doctors and patients with advanced tools. Driving innovation, growth, and excellence in its industry sectors.

Prescribe's top competitors include Lytus, Purple Health and Jiyyo.

Prescribe has 12 investors. Key investors include Angel List, Wellfound, First Cheque, Y Combinator, and Rohit Kumar Bansal.

The valuation of Prescribe is $897.94K as of Sep 2020.

Prescribe operates through Wellnexus Technologies Private Limited.

The legal entities of Prescribe currently have 3 directors, including Chandroth Ambiliyadan Sreeshyam, Nived Narayanan, Amit Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available